Total Payments
$8,327
2024 Payments
$1,839
Companies
21
Transactions
678
Medicare Patients
914
Medicare Billing
$137,089
Payment Breakdown by Category
Food & Beverage$8,327 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,327 | 678 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,797 | 151 | $0 (2024) |
| Alkermes, Inc. | $1,302 | 139 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $887.76 | 70 | $0 (2024) |
| ITI, Inc. | $756.44 | 46 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $721.59 | 86 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $676.35 | 61 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $362.85 | 21 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $355.94 | 15 | $0 (2024) |
| Lundbeck LLC | $266.77 | 16 | $0 (2024) |
| IRONSHORE PHARMACEUTICALS INC. | $234.40 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,839 | 120 | ABBVIE INC. ($406.45) |
| 2023 | $1,879 | 144 | ABBVIE INC. ($569.71) |
| 2022 | $2,388 | 220 | Alkermes, Inc. ($409.94) |
| 2021 | $2,222 | 194 | AbbVie Inc. ($433.60) |
All Payment Transactions
678 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $2.38 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.83 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $2.33 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: CNS | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $14.99 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/02/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $6.82 | General |
| Category: Neurology | ||||||
| 11/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.91 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: Central Nervous System | ||||||
| 11/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.39 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $5.52 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Neuropsychiatry | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $19.94 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/07/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Neuropsychiatry | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.22 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: PSYCHIATRY | ||||||
| 11/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 195 | 603 | $109,096 | $30,038 |
| 2022 | 7 | 234 | 690 | $117,250 | $34,517 |
| 2021 | 7 | 250 | 755 | $121,557 | $39,258 |
| 2020 | 5 | 235 | 707 | $114,781 | $33,276 |
Total Patients
914
Total Services
2,755
Medicare Billing
$137,089
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 276 | $65,499 | $17,008 | 26.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 52 | 172 | $23,236 | $6,700 | 28.8% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 16 | 34 | $5,848 | $1,710 | 29.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 25 | 50 | $3,650 | $1,578 | 43.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 40 | $6,647 | $1,570 | 23.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 31 | $4,216 | $1,473 | 34.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 307 | $64,375 | $19,252 | 29.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 57 | 188 | $25,143 | $7,167 | 28.5% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 20 | 45 | $7,740 | $2,339 | 30.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 23 | 54 | $7,344 | $2,303 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 52 | $7,658 | $2,063 | 26.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 11 | 14 | $2,800 | $782.89 | 28.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 19 | 30 | $2,190 | $611.24 | 27.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 98 | 382 | $75,694 | $23,723 | 31.3% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 68 | 196 | $24,413 | $7,881 | 32.3% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 20 | 42 | $6,804 | $2,331 | 34.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 19 | 46 | $6,256 | $2,093 | 33.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 11 | 20 | $2,500 | $1,304 | 52.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 21 | 55 | $4,015 | $1,265 | 31.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 14 | $1,875 | $661.12 | 35.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 114 | 403 | $79,792 | $21,215 | 26.6% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 69 | 194 | $23,530 | $8,047 | 34.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 26 | 61 | $4,453 | $1,575 | 35.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 15 | 31 | $4,216 | $1,476 | 35.0% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 11 | 18 | $2,790 | $963.26 | 34.5% |
About Suzanne Gregg, APRN
Suzanne Gregg, APRN is a Psychiatric/Mental Health healthcare provider based in Hastings, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2015. The National Provider Identifier (NPI) number assigned to this provider is 1710369103.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Suzanne Gregg, APRN has received a total of $8,327 in payments from pharmaceutical and medical device companies, with $1,839 received in 2024. These payments were reported across 678 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($8,327).
As a Medicare-enrolled provider, Gregg has provided services to 914 Medicare beneficiaries, totaling 2,755 services with total Medicare billing of $137,089. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Location Hastings, NE
- Active Since 06/23/2015
- Last Updated 06/23/2015
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1710369103
Products in Payments
- VRAYLAR (Drug) $1,797
- ARISTADA (Drug) $1,269
- CAPLYTA (Drug) $951.16
- REXULTI (Drug) $763.57
- INVEGA SUSTENNA (Drug) $721.59
- AUSTEDO (Drug) $396.47
- INGREZZA (Drug) $346.53
- ABILIFY MAINTENA (Drug) $278.76
- QELBREE (Drug) $246.18
- JORNAY PM (Drug) $234.40
- Austedo XR (Drug) $227.02
- Auvelity (Drug) $163.94
- LATUDA (Drug) $126.34
- Qelbree (Drug) $109.76
- HETLIOZ (Drug) $107.55
- PERSERIS (Drug) $99.28
- ABILIFY ASIMTUFII (Drug) $95.91
- VYVANSE (Drug) $60.21
- Wakix (Drug) $47.16
- AZSTARYS (Drug) $37.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Hastings
Dacia Oakeson, Np-C, NP-C
Psychiatric/Mental Health — Payments: $23,363
Psychiatric/Mental Health $23,363
Erica Ferrell, Np, NP
Psychiatric/Mental Health — Payments: $4,897
Psychiatric/Mental Health $4,897
Dr. Karena Rother, Dnp, Cnp, Pmhnp-Bc, DNP, CNP, PMHNP-BC
Psychiatric/Mental Health — Payments: $26.99
Psychiatric/Mental Health $26.99
Lori Smith
Psychiatric/Mental Health — Payments: $17.43
Psychiatric/Mental Health $17.43
Judith Luehr, Aprn, APRN
Psychiatric/Mental Health
Psychiatric/Mental Health
Siobhan Martinez, Aprn-Np, APRN-NP
Psychiatric/Mental Health
Psychiatric/Mental Health